Evidence map›Paper›PMID 42047202›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

DNA Nanoarray for Multiplexed RNA Detection With Single-Molecule Readout.

Yunxuan Li, Yesheng Wang, Chunmiao Yu, Siyu Hou, Elli Mylona, Plamena Naydenova, Jingyuan Zhao, Hong Yuan, Jingsong Duan, Hendrik F P Runge and 3 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Nanopore-Based Profiling of PEGylation in Nucleic Acid Therapeutics.Journal of the American Chemical Society · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yunxuan LiCavendish Laboratory, University of Cambridge, Cambridge, UK.
Yesheng WangSchool of Biomedical Engineering, Faculty of Medicine, Dalian University of Technology, Dalian, China.
Chunmiao YuSchool of Biomedical Engineering, Faculty of Medicine, Dalian University of Technology, Dalian, China.
Siyu HouCavendish Laboratory, University of Cambridge, Cambridge, UK.
Elli MylonaCambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffery Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.
Plamena NaydenovaCambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffery Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.
Jingyuan ZhaoCentral Hospital of Dalian University of Technology (Dalian Municipal Central Hospital), Dalian, China.
Hong YuanCentral Hospital of Dalian University of Technology (Dalian Municipal Central Hospital), Dalian, China.
Jingsong DuanSchool of Biomedical Engineering, Faculty of Medicine, Dalian University of Technology, Dalian, China.
Hendrik F P RungeCavendish Laboratory, University of Cambridge, Cambridge, UK.
Stephen BakerA*STAR Infectious Diseases Labs (A*STAR IDL), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Jinbo ZhuCavendish Laboratory, University of Cambridge, Cambridge, UK.
Ulrich F KeyserCavendish Laboratory, University of Cambridge, Cambridge, UK.

Funding

Cambridge Commonwealth European and International TrustChina Scholarship CouncilDalian Science and Technology Innovation Fund 2023JJ12SN032European Union under the Horizon 2020 ProgramFET- Open: DNA-FAIRYLIGHTS 964995Fundamental Research Funds for the Central Universities of China DUT23RC(3)029Fundamental Research Funds for the Central Universities of China DUT24YG211Liaoning Provincial Science and Technology Joint Fund 2023JH2/101800037Liaoning Provincial Science and Technology Joint Fund 2023JH2/101800039Liaoning Provincial Science and Technology Joint Fund 2025JH2/101900042Liaoning Revitalization Talent Program of China XLYC2403041National Natural Science Foundation of China 62471081UK Research and Innovation EP/X023311/1
6 · The paper itself

Abstract

Sensitive and multiplexed RNA analysis at the single-molecule level remains a key challenge in molecular diagnostics. Conventional fluorescence microarrays provide high throughput but lack molecular resolution, whereas single-molecule sensors such as nanopores offer exquisite precision but limited scalability. Here, we present a DNA carrier-based nanoarray that integrates programmable nucleic acid hybridization with solid-state nanopore readout for direct, multiplexed RNA detection. Each modular DNA carrier is pre-assembled with spatially defined probe sites that sequence-specifically capture RNA targets of varying lengths and conformations, in which poly(dT) sequences both structurally facilitate target binding and enhance signal strength without the need for fluorescent or protein labeling. Upon nanopore translocation, hybridized carrier-target complexes generate binary ionic current signatures, allowing single-molecule identification of target occupancy at each sensing site. Using a ternary coordinate encoding system, we constructed a nanoarray comprising 27 carriers with 81 addressable sensing sites, enabling simultaneous detection of multiple bacterial and viral RNA targets within a single assay directly from total RNA extracts without target-specific isolation, amplification, or enrichment. By combining the multiplexing capability of traditional microarrays with the single-molecule precision of nanopore sensing, this carrier-based nanoarray establishes a scalable, programmable, and universally adaptable framework for high-throughput molecular diagnostics in complex biological backgrounds.

Indexed as

DNANanotechnologyOligonucleotide Array Sequence AnalysisRNASingle Molecule ImagingNanoporesNucleic Acid HybridizationRNA, ViralDNARNARNA, ViralDNA nanotechnologymultiplexed molecular detectionprogrammable nanoarrayssingle‐molecule sensingsolid‐state nanopores

Identifiers

PMID42047202
PMCPMC13335565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.